• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Scopolamine augmentation for depressive symptoms and cognitive functions in treatment-resistant depression: A case series.

作者信息

Fang Yu, Guo Ping, Lv Liang, Feng Min, Wang Hong, Sun Guilan, Wang Shikai, Qian Mincai, Chen Huanxin

机构信息

Department of Psychiatry, The Third People's Hospital of Huzhou Municipal, The Affiliated Hospital of Huzhou University, Zhejiang, China.

Department of Psychiatry, The Third People's Hospital of Huzhou Municipal, The Affiliated Hospital of Huzhou University, Zhejiang, China.

出版信息

Asian J Psychiatr. 2023 Apr;82:103484. doi: 10.1016/j.ajp.2023.103484. Epub 2023 Jan 31.

DOI:10.1016/j.ajp.2023.103484
PMID:36736107
Abstract
摘要

相似文献

1
Scopolamine augmentation for depressive symptoms and cognitive functions in treatment-resistant depression: A case series.东莨菪碱增强难治性抑郁症的抑郁症状和认知功能：病例系列
Asian J Psychiatr. 2023 Apr;82:103484. doi: 10.1016/j.ajp.2023.103484. Epub 2023 Jan 31.
2
[Interest of scopolamine as a treatment of major depressive disorder].[东莨菪碱作为重度抑郁症治疗方法的研究意义]
Encephale. 2016 Dec;42(6):568-573. doi: 10.1016/j.encep.2016.06.002. Epub 2016 Sep 9.
3
Specific depressive symptoms predict remission to aripiprazole augmentation in late-life treatment resistant depression.特定的抑郁症状可预测老年难治性抑郁症患者使用阿立哌唑增效治疗后的缓解情况。
Int J Geriatr Psychiatry. 2018 Feb;33(2):e330-e335. doi: 10.1002/gps.4813. Epub 2017 Oct 3.
4
Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial.抗胆碱能药物东莨菪碱的抗抑郁疗效：一项随机、安慰剂对照临床试验。
Arch Gen Psychiatry. 2006 Oct;63(10):1121-9. doi: 10.1001/archpsyc.63.10.1121.
5
Predictors and Moderators of Remission With Aripiprazole Augmentation in Treatment-Resistant Late-Life Depression: An Analysis of the IRL-GRey Randomized Clinical Trial.阿立哌唑增效治疗难治性老年抑郁症缓解的预测因素和调节因素：IRL-GRey随机临床试验分析
JAMA Psychiatry. 2016 Apr;73(4):329-36. doi: 10.1001/jamapsychiatry.2015.3447.
6
Moderators of Remission in Patients With Late-Life Depression: Where Do We Go Next?老年抑郁症患者缓解的调节因素：我们接下来何去何从？
JAMA Psychiatry. 2016 Apr;73(4):319-20. doi: 10.1001/jamapsychiatry.2015.3458.
7
A randomized, double-blind, placebo-controlled, crossover trial evaluating the effect of intranasal insulin on cognition and mood in individuals with treatment-resistant major depressive disorder.一项随机、双盲、安慰剂对照、交叉试验，评估鼻内胰岛素对难治性重度抑郁症患者认知和情绪的影响。
J Affect Disord. 2017 Mar 1;210:57-65. doi: 10.1016/j.jad.2016.12.006. Epub 2016 Dec 18.
8
Role of Ketamine in Severe Depression with suicidal ideation - Insights from a Case Study.氯胺酮在伴有自杀意念的重度抑郁症中的作用——一项案例研究的见解
Asian J Psychiatr. 2017 Oct;29:112-113. doi: 10.1016/j.ajp.2017.04.022. Epub 2017 May 3.
9
Scopolamine augmentation of a newly initiated escitalopram treatment for major depressive disorder: study protocol for a randomized controlled trial.东莨菪碱增强新开始的艾司西酞普兰治疗重度抑郁症的疗效：一项随机对照试验的研究方案
Trials. 2019 Jan 9;20(1):33. doi: 10.1186/s13063-018-3132-3.
10
Evidence for the benefits of nonantipsychotic pharmacological augmentation in the treatment of depression.抗精神病药物增效治疗抑郁症的疗效证据。
CNS Drugs. 2013 May;27 Suppl 1:S21-7. doi: 10.1007/s40263-012-0030-1.